Get informed when a big investor buys or sells
+ FollowOvervalued by 99.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $164.56 Million |
|---|---|
| Enterprise Value | $164.54 Million |
| Earnings per Share | $0 |
| Beta | 6.22 |
| Outstanding Shares | 41,141,211 |
| P/E Ratio | -0.2 |
|---|---|
| PEG | 0.09 |
| Price to Sales | - |
| Price to Book Ratio | -4.0 |
| Enterprise Value to Revenue | 1917.09 |
| Enterprise Value to EBIT | -18.78 |
| Enterprise Value to Net Income | -39 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Zhengduozhe Technology Inc., operating as DAKOTA Life Sciences, is a biopharmaceutical enterprise dedicated to the acquisition, development, and commercialization of therapeutic agents. These pharmaceuticals are specifically engineered t...